
One of our McKesson experts discusses the importance of staying informed as 340B changes continue to unfold.
In this brief video, Heather Easterling provides important updates pertaining to the 340B program.
In this brief video, recorded in June 2024, Heather Easterling, PharmD, MBA, Vice President of 340B Solutions & Customer Contract Experience for McKesson Health Systems, provides important 340B updates, including:
Stay tuned for next quarter’s 340B updates, and contact us to learn more about how partnering with our 340B experts can help you achieve more.
One of our McKesson experts discusses the importance of staying informed as 340B changes continue to unfold.
At this year's event, our experts heard from health systems who may be underutilizing available tools and resources in 340B program management.
Our experts continue shaping industry conversations through regular conference and event engagements, like the HealthTrust University 340B Summit.
McKesson’s Head of Cell, Gene, and Advanced Therapies discusses opportunities and challenges with CGT in the health system.
In a unique, retreat-style setting, health systems leaders had close conversations around best practices, wins, struggles, and solutions.
Learn how McKesson is helping advance the 340B program through strategic customer engagement and insights.
Explore key trends and strategic recommendations from our experts to help you achieve more.
Three key benefits of exploring nontraditional partnerships with your distributor to achieve more.
Explore the ways we’re fortifying our supply chain and helping our customers continue to receive the medications they need.